Cargando…
Dexamethasone use in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: this “cort” is not out of order!
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887113/ https://www.ncbi.nlm.nih.gov/pubmed/34472452 http://dx.doi.org/10.4103/aja202155 |
| _version_ | 1784660824903647232 |
|---|---|
| author | Van Praet, Charles Fonteyne, Valérie Lumen, Nicolaas |
| author_facet | Van Praet, Charles Fonteyne, Valérie Lumen, Nicolaas |
| author_sort | Van Praet, Charles |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8887113 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88871132022-03-10 Dexamethasone use in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: this “cort” is not out of order! Van Praet, Charles Fonteyne, Valérie Lumen, Nicolaas Asian J Androl Invited Commentary Wolters Kluwer - Medknow 2021-08-27 /pmc/articles/PMC8887113/ /pubmed/34472452 http://dx.doi.org/10.4103/aja202155 Text en Copyright: ©The Author(s)(2021) https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Invited Commentary Van Praet, Charles Fonteyne, Valérie Lumen, Nicolaas Dexamethasone use in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: this “cort” is not out of order! |
| title | Dexamethasone use in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: this “cort” is not out of order! |
| title_full | Dexamethasone use in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: this “cort” is not out of order! |
| title_fullStr | Dexamethasone use in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: this “cort” is not out of order! |
| title_full_unstemmed | Dexamethasone use in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: this “cort” is not out of order! |
| title_short | Dexamethasone use in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: this “cort” is not out of order! |
| title_sort | dexamethasone use in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: this “cort” is not out of order! |
| topic | Invited Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887113/ https://www.ncbi.nlm.nih.gov/pubmed/34472452 http://dx.doi.org/10.4103/aja202155 |
| work_keys_str_mv | AT vanpraetcharles dexamethasoneuseinmetastaticcastrationresistantprostatecancerpatientstreatedwithabirateroneacetatethiscortisnotoutoforder AT fonteynevalerie dexamethasoneuseinmetastaticcastrationresistantprostatecancerpatientstreatedwithabirateroneacetatethiscortisnotoutoforder AT lumennicolaas dexamethasoneuseinmetastaticcastrationresistantprostatecancerpatientstreatedwithabirateroneacetatethiscortisnotoutoforder |